
FDA Panel Backs Four Peptides for Compounding: The Votes, the Evidence Dispute, and What It Actually Changes
PCAC cleared four peptides — but every yes came from June's new appointees, FDA's own scientists said no to all seven, and the law did not change. What the record actually shows.












